Chemotherapy Outcomes by Histologic Subtypes of Non-Small cell Lung Cancer: Analysis of the Southwest Oncology Group Database for Antimicrotubule-Platinum Therapy

Gelijkaardige items

• SOUTHWEST ONCOLOGY GROUP PHASE II TRIAL (S0341) OF ERLOTINIB (OSI-774) IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER AND A PERFORMANCE STATUS OF 2
  door: Hesketh, Paul J., et al.
  Gepubliceerd in: (2008)
• Phase II Selection Design Trial of Concurrent Chemotherapy and Cetuximab Versus Chemotherapy Followed by Cetuximab in Advanced-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Study S0342
  door: Herbst, Roy S., et al.
  Gepubliceerd in: (2010)
• COMPARISON OF PLATINUM BASED CHEMOTHERAPY IN PATIENTS OLDER AND YOUNGER THAN 70 YEARS OF AGE: AN ANALYSIS OF SOUTHWEST ONCOLOGY GROUP TRIALS 9308 AND 9509
  door: Blanchard, Elizabeth M., et al.
  Gepubliceerd in: (2011)
• Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003
  door: Mack, Philip C., et al.
  Gepubliceerd in: (2008)
• Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial
  door: Pisters, Katherine M.W., et al.
  Gepubliceerd in: (2010)